Streetbeat News

Stock Prices

META

Meta Platforms, Inc. (NASDAQ:META) shares hit all-time highs, trading above $500, following CEO Mark Zuckerberg's focus on AI, AR, and VR advancements, including meetings in Tokyo and with Samsung and LG Electronics on AI cooperation. Meta is set to unveil AR glasses codenamed Orion this fall. A U.S. court ruled in favor of Meta in a case against NSO Group over spyware. META's stock is up over 40% YTD, with analysts having a positive outlook despite the average target suggesting potential downside.

Portfolio Pulse from Erica Kollmann

March 01, 2024 | 7:04 pm

WMT

Recent options trading trends indicate a bearish stance on Walmart (NYSE:WMT) by significant investors, with a split sentiment of 38% bullish and 61% bearish. Uncommon options trades were spotted, including 6 puts and 7 calls, aiming for a price range of $50.0 to $86.67. Noteworthy options activity highlighted specific trades with varying sentiments. Walmart, a leading retailer in the US, is currently trading at $58.63, with a volume of 9,319,809. Market experts have issued ratings with a consensus target price of $137.2, suggesting a positive outlook despite the bearish options sentiment.

Portfolio Pulse from Benzinga Insights

March 01, 2024 | 7:02 pm

HPE

Five analysts have recently updated their ratings on Hewlett Packard (NYSE:HPE), showing a shift towards a more bearish sentiment with a decrease in the average price target by 11.58% to $16.8. The updates include lowered price targets by analysts from Stifel, Wells Fargo, Evercore ISI Group, Barclays, and Bernstein, reflecting changes in market conditions and company performance. Despite a decline in revenue by -6.61% and challenges in debt management, HPE maintains a strong net margin and ROA, indicating effective cost management and asset utilization.

Portfolio Pulse from Benzinga Insights

March 01, 2024 | 7:02 pm

XMRUSD

Monero (XMR) has seen a significant price increase of 3.81% in the last 24 hours, reaching $141.95, with a weekly gain of over 17% from $120.57. Despite a 53% decrease in trading volume over the week, its circulating supply slightly rose by 0.04% to 18.15 million. Currently, XMR's market cap ranks it 47th at $2.58 billion.

Portfolio Pulse from Benzinga Insights

March 01, 2024 | 7:01 pm

CCI

Over the past 20 years, Crown Castle (NYSE:CCI) has delivered an average annual return of 11.25%, outperforming the market by 3.47% annually. With a current market capitalization of $47.73 billion, an initial investment of $1000 in CCI 20 years ago would now be worth $8,305.37.

Portfolio Pulse from Benzinga Insights

March 01, 2024 | 7:01 pm

FMC

11 analysts have recently reviewed FMC Corporation (NYSE:FMC), showing mixed sentiments with a shift towards a more cautious outlook over the last three months. The average 12-month price target for FMC has been adjusted to $63.36 from $68.11, indicating a 6.97% decrease. Analysts from firms including Loop Capital, RBC Capital, and BMO Capital have adjusted their ratings and price targets, reflecting concerns over FMC's market position, revenue decline of -29.34%, and high debt-to-equity ratio despite strong net margin and ROE.

Portfolio Pulse from Benzinga Insights

March 01, 2024 | 7:00 pm

PK

Five analysts have recently updated their ratings on Park Hotels & Resorts (NYSE:PK), showing a positive shift in sentiment with an average 12-month price target of $18.00, up 23.29% from the previous $14.60. The updates include raised price targets and improved ratings, reflecting optimism about the company's market position and financial health. Despite a -3.24% decline in revenue growth as of December 31, 2023, Park Hotels & Resorts demonstrates strong profitability with a net margin of 28.46% and effective debt management.

Portfolio Pulse from Benzinga Insights

March 01, 2024 | 7:00 pm

DRD

EXK

GFI

MUX

Shares of precious metals stocks, including DRD, EXK, GFI, and MUX, are trading lower despite a rise in gold and silver prices.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 7:00 pm

CC

BMO Capital Markets analyst John P. McNulty downgraded The Chemours Company (NYSE:CC) to Underperform from Outperform with a new price target of $19, down from $45, citing management changes, delays in filing its 10-K, and financial struggles. Despite these challenges, McNulty notes early signs of recovery in core businesses but finds it high risk to make numeric earnings assumptions currently. Chemours expects FY23 net sales of about $6.0 billion, down from $6.8 billion the previous year.

Portfolio Pulse from Lekha Gupta

March 01, 2024 | 6:54 pm